Public procurement notice: Contract Notice
Published: 2018-07-12
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33641400 | 33641410
Estimated value: 12916611 GBP
Submission deadline: 2018-08-13
Award criteria: The most economic tender

Technical requirements: Framework Agreement for the supply of contraceptive medicines (oral, injection, intra-uterine, implant, gel and patch) to NHS Scotland.
All entities constituted pursuant to the National health service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public bodies (Joint working) Scotland Act 2014.
The Authority intends awarding as an unranked multi-supplier framework by product line. Each product line will be treated as an individual Lot and awarded to an envisaged maximum of 6 framework participants.
Option to extend by up to a total period of 24 months, upon giving not less than 3 months written notice such notice to expire no later than the date the Framework Agreement is due to expire.
All entities constituted pursuant to the National health service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public bodies (Joint working) Scotland Act 2014.
The Authority intends awarding as a ranked multi- supplier framework by product line. Each product line will be treated as an individual Lot and awarded to an envisaged maximum of 3 framework participants.
Option to extend by up to a total period of t24 months, upon giving not less than 3 months written notice such notice to expire no later than the date the Framework Agreement is due to expire.
All entities constituted pursuant to the National health service (Scotland) Act 1978, and any Integrated joint boards established pursuant to the new Public bodies (Joint working) Scotland Act 2014.
Supply of progesterone receptor modulators, progestogens, intra-uterine systems, injections, patch and gels to NHS Scotland.
Option to extend by up to a total period of 24 months, upon giving not less than 3 months written notice such notice to expire no later than the date the Framework Agreement is due to expire.
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) Potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing authorisation or EMA Marketing authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender;
(b) Potential framework participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered goods must comply with the MHRA best Practice guidance on labelling and packaging and the National patient safety agency ("NPSA") Guidelines on packaging and labelling on pack design.
(a) Confirmation of existence of a current and valid UK Marketing Authorisation that has been approved by the MHRA or EMEA(European Medicines Agency) market authorisation at the date of submission of the tender should be included in the Qualification envelope of the ITT under the Technical and professional ability: Quality control.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 12916611